Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$70.30

1.73 (2.52%)

06:40
10/06/16
10/06
06:40
10/06/16
06:40

Alnylam selloff a buying opportunity, says Piper Jaffray

Piper Jaffray analyst Edward Tenthoff views today's selloff in shares of Alnylam Pharmaceuticals after the company discontinued its revusiran program as a buying opportunity. The analyst does not believe the discontinuation has read-through to the Phase III APOLLO trial or seven other RNAi drugs that employ ESC-GalNAc technology. He lowered his price target for Alnylam shares to $106 from $118 and keeps an Overweight rating on the name. JPMorgan and Barclays this morning downgraded the shares.

  • 14

    Oct

  • 06

    Nov

ALNY Alnylam
$70.30

1.73 (2.52%)

09/15/16
FBRC
09/15/16
INITIATION
Target $82
FBRC
Underperform
FBR calls Alexion overvalued, starts shares at Underperform
FBR Capital analyst Christopher James initiated coverage of Alexion Pharmaceuticals (ALXN) with an Underperform rating and $82 price target. The biotech focused on patients with ultra-rare disorders closed yesterday up $2.63 to $129.42. Alexion shares are overpriced as the company is facing a competitive near-term landscape, particularly from Alnylam's (ALNY) ALN-CC5, James tells investors in a research note. Further, near-term expansion into additional indications will be challenging given the recent failed study with eculizumab in refractory generalized myasthenia gravis, the analyst contends. He also sees possible pricing pressures from biosimilars, including an Amgen (AMGN) biosimilar product in development. James this morning also initiated Achillion Pharmaceuticals (ACHN) and Arena Pharmaceuticals (ARNA) with Outperform ratings.
09/28/16
JANY
09/28/16
INITIATION
Target $74
JANY
Neutral
Alnylam initiated with a Neutral at Janney Capital
Janney Capital analyst Roy Buchanan initiated Alnylam with a Neutral and a $74 fair value estimate. The analyst is not confident about the outcome for the pivotal study for patisiran in transthyretin familial amyloid neuropathy, expected in about 12 months, and give patisiran a 50% chance of success.
10/06/16
LEHM
10/06/16
DOWNGRADE
Target $50
LEHM
Equal Weight
Alnylam downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoff Meacham downgraded Alnylam Pharmaceuticals (ALNY) to Equal Weight saying he views other SMid cap biotech names as more attractive following the company's recent pipeline setbacks. The analyst removed Revusiran sales from his Alnylam model after the program was discontinued yesterday and he cut his price target for the shares to $50 from $85. Meacham lists Neurocrine (NBIX), Prothena (PTRA) and Incyte (INCY) as names he finds more attractive over the next 12 months. Alnylam is trading down 44% in pre-market trading to $39.25.
10/06/16
JPMS
10/06/16
DOWNGRADE
Target $51
JPMS
Neutral
Alnylam downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anupam Rama downgraded Alnylam Pharmaceuticals to Neutral after the company said it will discontinue Revusiran for the treatment of Familial Amyloid Cardiomyopathy. The analyst viewed the drug as a "key asset" and cut his price target for the shares to $51 from $83. Barclays this morning also downgraded Alnylam.

TODAY'S FREE FLY STORIES

RATE

Bankrate

$12.33

-0.125 (-1.00%)

13:33
06/27/17
06/27
13:33
06/27/17
13:33
Periodicals
Bankrate jumps after rumor report published by Betaville »

Shares of Bankrate have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$157.50

-0.52 (-0.33%)

13:27
06/27/17
06/27
13:27
06/27/17
13:27
Technical Analysis
Technical View: Netflix trades near session lows »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

VRX

Valeant

$17.11

0.03 (0.18%)

13:25
06/27/17
06/27
13:25
06/27/17
13:25
Recommendations
Valeant analyst commentary  »

Valeant debt-for-equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

AGNC

AGNC Investment

$22.28

0.07 (0.32%)

13:25
06/27/17
06/27
13:25
06/27/17
13:25
Options
AGNC Investment Corp. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

13:20
06/27/17
06/27
13:20
06/27/17
13:20
General news
Treasury Action: yields extended their surge »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
06/27/17
06/27
13:17
06/27/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
06/27/17
06/27
13:16
06/27/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.27

0.25 (1.04%)

, XLK

Technology Select Sector SPDR

$55.52

-0.48 (-0.86%)

13:15
06/27/17
06/27
13:15
06/27/17
13:15
Technical Analysis
Technical View: S&P 500 mid-session chart update »

The S&P 500 (SPX) did…

XLF

Financial Select Sector

$24.27

0.25 (1.04%)

XLK

Technology Select Sector SPDR

$55.52

-0.48 (-0.86%)

SPY

SPDR S&P 500 ETF Trust

$242.76

-0.53 (-0.22%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.59

-1.48 (-0.95%)

13:08
06/27/17
06/27
13:08
06/27/17
13:08
Hot Stocks
Facebook reaches two billion users, Zuckerberg says »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AVAV

AeroVironment

$30.97

0.2 (0.65%)

13:07
06/27/17
06/27
13:07
06/27/17
13:07
Conference/Events
AeroVironment management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 03

    Jul

  • 04

    Jul

  • 05

    Jul

CBI

CB&I

$19.00

4.6 (31.94%)

13:05
06/27/17
06/27
13:05
06/27/17
13:05
Options
CB&I call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$109.93

-0.12 (-0.11%)

13:05
06/27/17
06/27
13:05
06/27/17
13:05
Hot Stocks
Quest Diagnostics announces intent to acquire CCHC outreach lab business »

Quest Diagnostics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

FOX

21st Century Fox

$27.62

0.69 (2.56%)

, FOXA

21st Century Fox

$28.04

0.85 (3.13%)

12:57
06/27/17
06/27
12:57
06/27/17
12:57
Hot Stocks
FOX Sports partners with Facebook to stream Champions League soccer »

Twenty-First Century…

FOX

21st Century Fox

$27.62

0.69 (2.56%)

FOXA

21st Century Fox

$28.04

0.85 (3.13%)

FB

Facebook

$153.59

-1.48 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

DHXM

DHX Media

$4.15

-0.0367 (-0.88%)

12:56
06/27/17
06/27
12:56
06/27/17
12:56
Conference/Events
DHX Media management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

IVZ

Invesco

$35.01

-0.005 (-0.01%)

12:55
06/27/17
06/27
12:55
06/27/17
12:55
Conference/Events
Invesco management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

FDX

FedEx

$215.36

-0.0025 (-0.00%)

12:52
06/27/17
06/27
12:52
06/27/17
12:52
Periodicals
TNT Express says hit with 'interference' with some of its systems, ABC News says »

A spokesman for TNT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

FDX

FedEx

12:50
06/27/17
06/27
12:50
06/27/17
12:50
Periodicals
FedEx 'operating normally' after functionality issues, Reuters reports »

A spokeswoman for FedEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

THC

Tenet

$19.43

0.6587 (3.51%)

12:50
06/27/17
06/27
12:50
06/27/17
12:50
Options
3K Tenet Healthcare Jul 20 calls trade for 88c »

3K Tenet Healthcare Jul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

, WFM

Whole Foods

$42.69

-0.255 (-0.59%)

12:48
06/27/17
06/27
12:48
06/27/17
12:48
Hot Stocks
Kroger CEO: Whole Foods 'great fit' for Amazon »

Speaking in a CNBC…

AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

WFM

Whole Foods

$42.69

-0.255 (-0.59%)

KR

Kroger

$22.97

0.355 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

SMSMY

Sims Metal

$10.30

-0.03 (-0.29%)

12:47
06/27/17
06/27
12:47
06/27/17
12:47
Upgrade
Sims Metal rating change  »

Sims Metal upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
06/27/17
06/27
12:45
06/27/17
12:45
General news
Breaking General news story  »

Federal Reserve Chair…

12:45
06/27/17
06/27
12:45
06/27/17
12:45
Conference/Events
Federal Reserve Board Chair Yellen speaks on global economic issues »

Federal Reserve Board…

DD

DuPont

$80.85

-0.31 (-0.38%)

, DOW

Dow Chemical

$63.30

-0.27 (-0.42%)

12:43
06/27/17
06/27
12:43
06/27/17
12:43
Periodicals
Mexico's Cofece grants conditional approval of DuPont-Dow tie-up, Reuters says »

Mexico's Federal…

DD

DuPont

$80.85

-0.31 (-0.38%)

DOW

Dow Chemical

$63.30

-0.27 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TGT

Target

$52.22

0.74 (1.44%)

, AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

12:41
06/27/17
06/27
12:41
06/27/17
12:41
Periodicals
Target prices next-day delivery service test $1 below Amazon's, StarTribune says »

Target (TGT), which just…

TGT

Target

$52.22

0.74 (1.44%)

AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CBI

CB&I

$19.08

4.68 (32.50%)

12:34
06/27/17
06/27
12:34
06/27/17
12:34
Hot Stocks
CB&I says court vindicates position in lawsuit against Westinghouse »

CB&I issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.